Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Number of machines

<< Previous

Bullboard Posts

Next >>

Comment by 007daveon Sep 24, 2020 12:49pm

122 Views

Post# 31611929

RE:Number of machines

From my understanding from the clinical trials they then submit that data to FDA, so FDA does not need a machine. But I agree with the rest of your points. Unfortunately the news flow out of LXG is pathetic so we have no idea what Mr Anderson is accomplished or FDA status.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo